TERM ID="NYU_TERM_1" STRING="Cancer gene therapy" FREQUENCY=1 START=0 END=19 LEMMA="CANCER GENE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="antitumor efficacy" FREQUENCY=2 START=525 END=543 LEMMA="ANTITUMOR EFFICACY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="antitumor efficacy" FREQUENCY=2 START=788 END=806 LEMMA="ANTITUMOR EFFICACY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="cancer cell" FREQUENCY=1 START=731 END=742 LEMMA="CANCER CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="cancer cell selective replication" FREQUENCY=1 START=731 END=764 LEMMA="SELECTIVE REPLICATION CANCER CELL" LEMMA_FREQUENCY=1 HEAD_TERM="selective replication" HEAD_LEMMA="SELECTIVE REPLICATION"
TERM ID="NYU_TERM_6" STRING="cancer gene therapy approaches" FREQUENCY=1 START=313 END=343 LEMMA="CANCER GENE THERAPY APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="cancer patients" FREQUENCY=1 START=631 END=646 LEMMA="CANCER PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="clinical approaches" FREQUENCY=1 START=922 END=941 LEMMA="CLINICAL APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="clinical trials" FREQUENCY=1 START=450 END=465 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="curative" FREQUENCY=1 START=142 END=150 LEMMA="CURATIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="gene therapy hold promise" FREQUENCY=1 START=220 END=245 LEMMA="GENE THERAPY HOLD PROMISE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="lyse tumor cells" FREQUENCY=1 START=415 END=431 LEMMA="LYSE TUMOR CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="oncolytic adenoviruses" FREQUENCY=2 START=348 END=370 LEMMA="ONCOLYTIC ADENOVIRUS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_14" STRING="oncolytic adenoviruses" FREQUENCY=2 START=947 END=969 LEMMA="ONCOLYTIC ADENOVIRUS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="oncolytic adenoviruses Metastatic cancer" FREQUENCY=1 START=25 END=65 LEMMA="ONCOLYTIC ADENOVIRUSES METASTATIC CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="overview" FREQUENCY=1 START=891 END=899 LEMMA="OVERVIEW" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="selective replication" FREQUENCY=1 START=743 END=764 LEMMA="SELECTIVE REPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="side effects" FREQUENCY=1 START=171 END=183 LEMMA="SIDE EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="targeted approaches" FREQUENCY=1 START=192 END=211 LEMMA="TARGETED APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="targeting strategies" FREQUENCY=1 START=671 END=691 LEMMA="TARGETING STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="therapeutic transgenes" FREQUENCY=1 START=832 END=854 LEMMA="THERAPEUTIC TRANSGENE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="treatment alternative" FREQUENCY=1 START=605 END=626 LEMMA="TREATMENT ALTERNATIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="treatment alternative for cancer patients" FREQUENCY=1 START=605 END=646 LEMMA="CANCER PATIENT TREATMENT ALTERNATIVE" LEMMA_FREQUENCY=1 HEAD_TERM="treatment alternative" HEAD_LEMMA="TREATMENT ALTERNATIVE"
TERM ID="NYU_TERM_24" STRING="tumor cell transduction" FREQUENCY=1 START=703 END=726 LEMMA="TUMOR CELL TRANSDUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="tumor types" FREQUENCY=1 START=275 END=286 LEMMA="TUMOR TYPE" LEMMA_FREQUENCY=1
